CHLORHEXIDINE GLUCONATE - Generic Drug Details

What are the generic sources for chlorhexidine gluconate and what is the scope of freedom to operate?

Chlorhexidine gluconate is the generic ingredient in twenty-eight branded drugs marketed by Xttrium, Sage Prods, Medline Industries, Bajaj, Chartwell Rx, Lyne, Pharm Assoc, Pharmobedient, Sciegen Pharms, Sunstar Americas, 3M, Colgate Palmolive Co, Colgate-palmolive Co, Soapco, Ecolab, Molnlycke Hlth, J And J, Matrix Medcl, Griffen, Becton Dickinson, Kendall Il, Carefusion 2200, Dexcel Pharma, 3m Health Care, Becton Dickinson Co, and Prof Dspls, and is included in thirty-six NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Chlorhexidine gluconate has three patent family members in one country.

There are twenty-seven drug master file entries for chlorhexidine gluconate. Fifty-eight suppliers are listed for this compound.

Summary for CHLORHEXIDINE GLUCONATE

International Patents:	3
US Patents:	3
Tradenames:	28
Applicants:	26
NDAs:	36
Drug Master File Entries:	27
Finished Product Suppliers / Packagers:	58
Raw Ingredient (Bulk) Api Vendors:	42
Clinical Trials:	179
Drug Prices:	Drug price trends for CHLORHEXIDINE GLUCONATE
What excipients (inactive ingredients) are in CHLORHEXIDINE GLUCONATE?	CHLORHEXIDINE GLUCONATE excipients list
DailyMed Link:	CHLORHEXIDINE GLUCONATE at DailyMed

See drug prices for CHLORHEXIDINE GLUCONATE

See drug sales revenues for CHLORHEXIDINE GLUCONATE

Recent Clinical Trials for CHLORHEXIDINE GLUCONATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Mariam Hesham Mahmoud Abdelfattah Eissa	NA
Aydin Adnan Menderes University	PHASE4
Harran University	NA

See all CHLORHEXIDINE GLUCONATE clinical trials

Pharmacology for CHLORHEXIDINE GLUCONATE

Physiological Effect

Decreased Cell Wall Integrity

Medical Subject Heading (MeSH) Categories for CHLORHEXIDINE GLUCONATE

Anti-Infective Agents, Local

Disinfectants

Mouthwashes

Anatomical Therapeutic Chemical (ATC) Classes for CHLORHEXIDINE GLUCONATE

A01AB	Antiinfectives and antiseptics for local oral treatment
A01A	STOMATOLOGICAL PREPARATIONS
A01	STOMATOLOGICAL PREPARATIONS
A	Alimentary tract and metabolism

B05CA	Antiinfectives
B05C	IRRIGATING SOLUTIONS
B05	BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B	Blood and blood forming organs

D08AC	Biguanides and amidines
D08A	ANTISEPTICS AND DISINFECTANTS
D08	ANTISEPTICS AND DISINFECTANTS
D	Dermatologicals

D09AA	Medicated dressings with antiinfectives
D09A	MEDICATED DRESSINGS
D09	MEDICATED DRESSINGS
D	Dermatologicals

R02AA	Antiseptics
R02A	THROAT PREPARATIONS
R02	THROAT PREPARATIONS
R	Respiratory system

S01AX	Other antiinfectives
S01A	ANTIINFECTIVES
S01	OPHTHALMOLOGICALS
S	Sensory organs

S02AA	Antiinfectives
S02A	ANTIINFECTIVES
S02	OTOLOGICALS
S	Sensory organs

S03AA	Antiinfectives
S03A	ANTIINFECTIVES
S03	OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS
S	Sensory organs

US Patents and Regulatory Information for CHLORHEXIDINE GLUCONATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Becton Dickinson Co	CHLORAPREP SINGLE SWABSTICK	chlorhexidine gluconate; isopropyl alcohol	SWAB;TOPICAL	021555-002	May 10, 2005		OTC	Yes	Yes
Xttrium	EXIDINE	chlorhexidine gluconate	SOLUTION;TOPICAL	019125-001	Dec 24, 1984		OTC	No	No
Prof Dspls	PREVANTICS SWAB	chlorhexidine gluconate; isopropyl alcohol	SWAB;TOPICAL	021524-001	Jun 3, 2005		OTC	Yes	Yes
Bajaj	CHLORHEXIDINE GLUCONATE	chlorhexidine gluconate	SOLUTION;TOPICAL	020111-001	Sep 11, 1997		OTC	No	No

Expired US Patents for CHLORHEXIDINE GLUCONATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Dexcel Pharma	PERIOCHIP	chlorhexidine gluconate	TABLET;DENTAL	020774-001	May 15, 1998
Sage Prods	CHLORHEXIDINE GLUCONATE	chlorhexidine gluconate	CLOTH;TOPICAL	021669-001	Apr 25, 2005
Molnlycke Hlth	HIBICLENS	chlorhexidine gluconate	SPONGE;TOPICAL	018423-001	Approved Prior to Jan 1, 1982
Dexcel Pharma	PERIOCHIP	chlorhexidine gluconate	TABLET;DENTAL	020774-001	May 15, 1998

International Patents for CHLORHEXIDINE GLUCONATE

Country	Patent Number	Title	Estimated Expiration
Canada	2551688	DEBARBOUILLETTE NON TISSEE AMELIOREE (IMPROVED NON-WOVEN WASH CLOTH)
Canada	2467155	DISPOSITIF D'ADMINISTRATION DE DESINFECTANT ET METHODE DE DESINFECTION SANS ALCOOL (DISINFECTANT DELIVERY SYSTEM AND METHOD OF PROVIDING ALCOHOL-FREE DISINFECTION)
Canada	2467150	DISPOSITIF D'ADMINISTRATION DE DESINFECTANT ET METHODE DE DESINFECTION SANS ALCOOL (DISINFECTANT DELIVERY SYSTEM AND METHOD OF PROVIDING ALCOHOL-FREE DISINFECTION)

Market Dynamics and Financial Trajectory for Chlorhexidine Gluconate

Last updated: February 19, 2026

Chlorhexidine gluconate (CHG) is a broad-spectrum antimicrobial agent primarily used in healthcare settings. Its market is driven by infection control protocols, dental applications, and emerging uses in other antimicrobial products. The following outlines current market conditions, growth drivers, competitive landscape, and financial projections.

Market Size and Growth Trends

Global Market Valuation

The global chlorhexidine gluconate market was valued at approximately USD 600 million in 2022. Projections estimate a compound annual growth rate (CAGR) of 4.2% from 2023 to 2030, reaching nearly USD 900 million by 2030.[1]

Regional Breakdown

• North America: Largest market, driven by hospital-acquired infection (HAI) prevention and dental practices.
• Europe: Similar growth trajectory; strong regulations promote antiseptic use.
• Asia-Pacific: Fastest-growing due to expanding healthcare infrastructure and increasing oral health awareness.

Segment Insights

• Healthcare (preoperative skin disinfection, hand sanitizers): 60% of total revenue.
• Dental (mouth rinses, periodontal therapy): 30%.
• Other applications: 10%, including consumer antiseptic products.

Drivers of Market Growth

Increasing Hospital-Acquired Infection (HAI) Prevention

Stringent infection control protocols have amplified demand for chlorhexidine gluconate in surgical preparations and skin disinfection. The CDC recommends CHG for central line-associated bloodstream infection (CLABSI) prevention, influencing hospital procurement policies.

Dental Care Expansion

Growing global awareness regarding oral hygiene therapies enhances demand for CHG mouthwashes. The expansion of dental services in emerging markets further accelerates adoption.

Rising Consumer and Institutional Use

The COVID-19 pandemic heightened public and institutional interest in antimicrobial agents. Hand sanitizers and surface disinfectants containing CHG have gained popularity outside healthcare settings.

Regulatory Environment

Stringent regulations governing infection prevention, especially in Europe and North America, facilitate consistent demand. The U.S. FDA and EMA approval processes reinforce product safety and efficacy standards.

Emerging Applications

Research and development efforts expand CHG's use in skin anti-irritant formulations, wound care products, and antimicrobial textiles. These novel applications could diversify revenue sources.

Competitive Landscape

Major Players

• Angelini Pharma
• 3M Company
• Akorn, Inc.
• CuraScript SD (a subsidiary of McKesson)
• S.C. Johnson & Son, Inc.

Market Share Distribution

The top five companies constitute roughly 65% of the market, with Angelini Pharma and 3M leading in revenues. Consolidation trends suggest acquisition activity aimed at expanding distribution channels and R&D capabilities.

Pricing Dynamics

Prices are influenced by raw material costs (notably chlorinated phenyl compounds), regional regulations, and competitive pressures. Manufacturers face rising costs due to supply chain disruptions for raw materials.

Financial Trajectory and Investment Outlook

Revenue Trends

Revenue growth is projected at an average of 4.2% CAGR to 2030, with North America leading growth in hospital and dental segments. Market expansion in developing economies supports this trajectory.

Investment in R&D

Significant investments focus on formulating higher-concentration products, developing formulations with reduced irritation profiles, and exploring new delivery systems such as liposomal or controlled-release formulations.

Profitability and Pricing Trends

Gross margins maintain around 40-50%. Price stabilization is expected due to steady demand, although raw material costs may influence margins marginally.

Regulatory Impact

Approval pathways for new formulations and uses in various jurisdictions are complex. Changes in antimicrobial regulations, like the antimicrobial stewardship initiatives, could restrict certain uses, impacting revenues.

Risks and Challenges

• Emerging resistance: Microbial resistance to chlorhexidine could reduce efficacy, prompting shifts to alternative agents.
• Regulatory restrictions: New legislation may limit formulary inclusion or increase compliance costs.
• Raw material supply: Disruptions in manufacturing supply chains may impact production volumes and pricing.
• Market saturation: Mature markets may experience slow growth, requiring diversification into emerging applications.

Summary of Key Financial Data

Parameter	2022	2030 (projected)	CAGR
Market Size (USD)	USD 600M	USD 900M	4.2%
North America Market Share	45%	-	-
Price per unit (average)	USD 0.10-0.20	-	-
Major Revenue Contributors	Hospital disinfectants, dental products	-	-

Sources: [1] Business Research Company; [2] MarketsandMarkets; [3] GlobalData.

Key Takeaways

• The chlorhexidine gluconate market is expanding steadily, driven by infection prevention and oral health awareness.
• North America remains the dominant market, but Asia-Pacific offers significant growth potential.
• Market growth depends on regulatory developments, resistance patterns, and raw material costs.
• Leading companies focus on innovation in formulations and expanding application areas.
• Supply chain resilience and regulatory adaptation will be critical to maintaining positive financial trajectories.

FAQs

1. What are the primary markets for chlorhexidine gluconate?
Healthcare (disinfection, surgical prep), dental care (mouth rinses), and consumer antiseptics.

2. How is resistance affecting chlorhexidine gluconate use?
Emerging microbial resistance may diminish effectiveness, leading to reduced usage in certain clinical applications.

3. What are opportunities for growth outside traditional markets?
Research into antimicrobial textiles, wound dressings, and skin anti-irritants presents new revenue channels.

4. How do raw material costs influence profitability?
Supply disruptions and price volatility for chlorinated phenyl compounds can reduce margins if not managed effectively.

5. What regulatory factors impact market expansion?
Stringent approval processes and antimicrobial stewardship policies may restrict or delay new formulations and uses.

---

References

[1] Business Research Company. (2023). Chlorhexidine Gluconate Market Report.
[2] MarketsandMarkets. (2022). Antiseptic Market by Product, Application, and Region.
[3] GlobalData. (2022). Antimicrobial Solutions Market Forecast.